tert-Butyl (2R)-2-methyl-3-oxoazetidine-1-carboxylate, 98%, 250mg

(E)-Methyl 3-(2-nitrophenyl)acrylate, 95.0%, 5g

(R)-tert-Butyl 3-(chloromethyl)pyrrolidine-1-carboxylate, 95.0%, 5g

(R)-2-Benzyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole, 97%, 250mg

3-Aminopropanamide hydrochloride, 97.00%, 1g

Bomba de vacío de membrana LABOPORT® Mini, N 816.3 KT.18, 16 l/min, 20 mbar, 1 pieza

6-Benzyl-4-chloro-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine, 95.0%, 100mg

(2E)-1-(2,4-dichlorophenyl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one, 95.0%, 2g

(R)-(2-Methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazol-2-yl)methanol, 97%, 250mg

3-(4-Nitro-phenyl)-L-alanine ethyl ester hydrochloride, 97.0%, 5g

4,4-Dimethylisoquinoline-1,3(2H,4H)-dione, 95%, 100mg

Adamantanol, mínimo 99 %, para síntesis, 250 g, envase de vidrio

4-(Aminomethyl)benzaldehyde hydrochloride, 95%, 250mg